Evidence map›Paper›PMID 42671198›Full record

ArticlemSphere2026

Aerosol-based disinfection protocol for aircraft: a solution for the conflict between material compatibility and antimicrobial efficacy.

Sandro Klafack, Jessica Kohs, Karla A Schwenke, Paul Siller, Janina Reißner, Holger Freese, Alina Below, Tim Lübcke, Stefan Mehler, Bernd Albert and 10 more

Abstract read
In one paragraph

Article in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sandro Klafack *Department of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Jessica Kohs *Department of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Karla A Schwenke *Division Hospital Hygiene, Infection Prevention and Control, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Paul SillerInstitute for Animal Hygiene and Environmental Health, Freie Universität Berlin, Berlin, Germany.
Janina ReißnerInstitute for Animal Hygiene and Environmental Health, Freie Universität Berlin, Berlin, Germany.
Holger FreeseDepartment of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Alina BelowDepartment of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Tim LübckeLufthansa Technik AG, Hamburg, Germany.
Stefan MehlerLufthansa Technik AG, Frankfurt am Main, Germany.
Bernd AlbertLufthansa Technik AG, Frankfurt am Main, Germany.
Heiko BarthLufthansa Technik AG, Frankfurt am Main, Germany.
Sabine HoelterhoffLufthansa Technik AG, Frankfurt am Main, Germany.
Mathias StreitzDepartment of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Marcell EngelAKUT SOS CLEAN GmbH (SOS), Frankfurt am Main, Germany.
Jan SchinkötheInstitute of Veterinary Pathology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.ORCID 0000-0002-3426-3090
Hendrik A ScheinemannDepartment of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.ORCID 0000-0002-4275-7672
Marc ThanheiserDivision Hospital Hygiene, Infection Prevention and Control, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Uwe RöslerInstitute for Animal Hygiene and Environmental Health, Freie Universität Berlin, Berlin, Germany.
Jens TeifkeDepartment of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Sven ReicheDepartment of Experimental Animal Facilities and Biorisk Management (ATB), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.ORCID 0000-0001-7575-2483

Funding

Federal Ministry of Health, Federal Republic of Germany ZMVI1-2520COR413
6 · The paper itself

Abstract

Every year, billions of passengers, pets, and livestock are transported by air, which increases the risk of a global spread of pathogens like severe acute respiratory syndrome coronavirus 1 and 2, H1N1 influenza, the Ebola virus, and foot-and-mouth disease virus. However, due to its complexity and high safety standards, aircraft decontamination is limited to manual surface disinfection, and an approved method for disinfecting otherwise inaccessible areas is still unavailable. To address this issue, we present the development and validation of an effective room disinfection method utilizing low concentrations of aerosolized peroxyacetic acid (aPAA), stabilized by hydrogen peroxide, known as "dry fog." Therefore, we determined the minimal effective antimicrobial concentration of aPAA for a wide range of agents, including bacteria, viruses, and bacterial endospores. Then, we applied the developed disinfection protocol to a large panel of relevant materials multiple times in the context of the official material compatibility tests (MCTs) requested by the European Union Aviation Safety Agency (EASA) to demonstrate that its application will not cause a negative effect on the aircraft airworthiness. After successfully passing these complex material compatibility tests, we finally validated the disinfection protocol within a narrow-body aircraft A320 for its antimicrobial efficacy by using the most resistant microorganisms to aPAA among our test organisms, the bacteriophage MS2, and spores of IMPORTANCE: Despite numerous outbreaks in recent years, particularly the Ebola virus epidemic and the severe acute respiratory syndrome coronavirus 2 pandemic, there is still no approved method for disinfecting contaminated aircraft. Due to the highly complex nature of aircraft material and technology, it is difficult to balance the antimicrobial efficacy and material compatibility of the biocides used in a way that meets high safety standards. Here, we demonstrate an aerosol-based disinfection protocol using a mixture of peracetic acid and hydrogen peroxide. This protocol passed all material compatibility tests according to relevant aircraft certification specifications established by the European Union Aviation Safety Agency, as well as the manufacturer qualification test programs, and proved to be highly effective against viruses, bacteria, and even bacterial endospores without compromising the airworthiness of the aircraft. By targeting both contaminated surfaces and objects, as well as airborne pathogen reservoirs, it minimizes the spillover risk of zoonotic agents and prevents the mechanical transmission of high-consequence agricultural pathogens into disease-free geographical regions. This makes it the first suitable semi-automatic airborne disinfection method that can be used in addition to routine manual surface disinfection following contamination resulting from contact with people, animals, or goods infected or contaminated with high-consequence pathogens.

Indexed as

AircraftDisinfectantsDisinfectionPeracetic AcidAerosolsBacteriaHydrogen PeroxideSpores, BacterialVirusesAerosolsDisinfectantsHydrogen PeroxidePeracetic Acidaerosol-basedaircraftdisinfectiondry fogperoxyacetic acid

Identifiers

PMID42671198
PMCPMC13639886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.